Cargando…
Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector
Industry 4.0 (I4.0) is helping production units to become smarter using cyber-physical systems and cognitive intelligence. The advanced diagnostics with I4.0 technologies (I4.0t) help in making the process highly flexible, resilient and autonomous. Still, the adoption of I4.0t especially in emerging...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214346/ https://www.ncbi.nlm.nih.gov/pubmed/37361066 http://dx.doi.org/10.1007/s10479-023-05391-6 |
_version_ | 1785047821750108160 |
---|---|
author | Sharma, Mahak Sehrawat, Rajat Giannakis, Mihalis Dwivedi, Yogesh K. |
author_facet | Sharma, Mahak Sehrawat, Rajat Giannakis, Mihalis Dwivedi, Yogesh K. |
author_sort | Sharma, Mahak |
collection | PubMed |
description | Industry 4.0 (I4.0) is helping production units to become smarter using cyber-physical systems and cognitive intelligence. The advanced diagnostics with I4.0 technologies (I4.0t) help in making the process highly flexible, resilient and autonomous. Still, the adoption of I4.0t especially in emerging economies like India is at a very slow pace. The present research has used an integrated approach i.e., Analytical Hierarchy Process-Combinative Distance-Based Assessment-Decision-Making Trial and Evaluation Laboratory to propose a barrier solution framework using data from pharmaceutical manufacturing sector. The findings reveal that “Costly venture” is found to be the most critical deterrent while “Customer awareness and satisfaction” is one of the potential solutions for I4.0t adoption. Further, lack of standardisation and fair benchmarking policies especially in the context of developing economies needs immediate attention. This article concludes by proposing a framework which will help to move from I4.0 towards Industry 4.0 + (I4.0+) which emphasises on role of collaboration between man and machine. And leads to sustainable supply chain management. |
format | Online Article Text |
id | pubmed-10214346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-102143462023-05-30 Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector Sharma, Mahak Sehrawat, Rajat Giannakis, Mihalis Dwivedi, Yogesh K. Ann Oper Res Original Research Industry 4.0 (I4.0) is helping production units to become smarter using cyber-physical systems and cognitive intelligence. The advanced diagnostics with I4.0 technologies (I4.0t) help in making the process highly flexible, resilient and autonomous. Still, the adoption of I4.0t especially in emerging economies like India is at a very slow pace. The present research has used an integrated approach i.e., Analytical Hierarchy Process-Combinative Distance-Based Assessment-Decision-Making Trial and Evaluation Laboratory to propose a barrier solution framework using data from pharmaceutical manufacturing sector. The findings reveal that “Costly venture” is found to be the most critical deterrent while “Customer awareness and satisfaction” is one of the potential solutions for I4.0t adoption. Further, lack of standardisation and fair benchmarking policies especially in the context of developing economies needs immediate attention. This article concludes by proposing a framework which will help to move from I4.0 towards Industry 4.0 + (I4.0+) which emphasises on role of collaboration between man and machine. And leads to sustainable supply chain management. Springer US 2023-05-26 /pmc/articles/PMC10214346/ /pubmed/37361066 http://dx.doi.org/10.1007/s10479-023-05391-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Sharma, Mahak Sehrawat, Rajat Giannakis, Mihalis Dwivedi, Yogesh K. Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector |
title | Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector |
title_full | Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector |
title_fullStr | Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector |
title_full_unstemmed | Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector |
title_short | Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector |
title_sort | learnings from industry 4.0 for transitioning towards industry 4.0+: challenges and solutions for indian pharmaceutical sector |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214346/ https://www.ncbi.nlm.nih.gov/pubmed/37361066 http://dx.doi.org/10.1007/s10479-023-05391-6 |
work_keys_str_mv | AT sharmamahak learningsfromindustry40fortransitioningtowardsindustry40challengesandsolutionsforindianpharmaceuticalsector AT sehrawatrajat learningsfromindustry40fortransitioningtowardsindustry40challengesandsolutionsforindianpharmaceuticalsector AT giannakismihalis learningsfromindustry40fortransitioningtowardsindustry40challengesandsolutionsforindianpharmaceuticalsector AT dwivediyogeshk learningsfromindustry40fortransitioningtowardsindustry40challengesandsolutionsforindianpharmaceuticalsector |